Search

Author/Creator Silverman, Lewis R

1. Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. Issue 4 (April 2016)

Authors:
Garcia-Manero, Guillermo; Fenaux, Pierre; Al-Kali, Aref; Baer, Maria R; Sekeres, Mikkael A; Roboz, Gail J; Gaidano, Gianluca; Scott, Bart L; Greenberg, Peter; Platzbecker, Uwe; Steensma, David P; Kambhampati, Suman; Kreuzer, Karl-Anton; Godley, Lucy A; Atallah, Ehab; Collins, Robert; Kantarjian, ...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 4(2016:Apr.)
Page Start:
496
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Issue 8 (August 2020)

Authors:
Zeidan, Amer M; Boddu, Prajwal C; Patnaik, Mrinal M; Bewersdorf, Jan Philipp; Stahl, Maximilian; Rampal, Raajit K; Shallis, Rory; Steensma, David P; Savona, Michael R; Sekeres, Mikkael A; Roboz, Gail J; DeAngelo, Daniel J; Schuh, Andre C; Padron, Eric; Zeidner, Joshua F; Walter, Roland B; Onida, ...
Journal:
Lancet
Issue:
Volume 7:Issue 8(2020)
Page Start:
e601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search